收藏切换
Advances of inhaled vaccine research
收藏切换
PDF
Ting-ting SUN1, 2, Qiu-hui GUO1, Feng ZHAO1, Xiao-jie XU1, Yong-hong LIAO2, Yun-fei LI1, 3, *
Acta Pharmaceutica Sinica | 2025, 60(4) : 875 - 883
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(4): 875-883
Reviews
Advances of inhaled vaccine research
Full
Ting-ting SUN1, 2, Qiu-hui GUO1, Feng ZHAO1, Xiao-jie XU1, Yong-hong LIAO2, Yun-fei LI1, 3, *
Affiliations
  • 1Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
  • 2Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China
  • 3Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, Shandong University, Qingdao 266237, China
Published: 2025-04-12 doi: 10.16438/j.0513-4870.2024-0984
Outline
收藏切换

Respiratory infections, as common diseases, along with other respiratory system diseases such as asthma, rare diseases including cystic fibrosis, chronic obstructive pulmonary disease, and lung cancer, can be prevented using vaccines. Taking respiratory infections as an example, vaccines are mostly administered via intramuscular injection, inducing the production of serum IgG, thereby neutralizing viral infectivity and alleviating COVID-19 symptoms. However, due to the lack of secretory IgA and IgG in muscle tissues, intramuscular vaccines cannot quickly provide protection to the respiratory tract. To overcome the shortcomings of intramuscular injection, some vaccine candidates for nasal or nebulized inhalation are under development or have been approved. Clinical studies show that inhaled vaccines can induce antibody responses similar to those of intramuscular vaccines at much lower doses. Inhaled vaccines can simultaneously induce humoral, cellular, and mucosal immunity, providing triple protection. With the application of new vaccines (e.g. mRNA vaccines and DNA vaccines) in inhalable formulations for COVID-19, inhaled vaccines have been proven to have broad application prospects in the prevention of lung diseases. Given this background and the known abundance of immune cells in the lungs, increasing research efforts are devoted to developing single-dose inhalable nano dry powder vaccines. This article discusses the roles and advantages of inhaled vaccines in mucosal immunity, their potentials for treating different diseases, and prospects for the future development of inhaled vaccines based on nanotechnology.

respiratory infection  /  inhaled vaccine  /  mucosal immunity  /  delivery vectors  /  delivery device
Ting-ting SUN, Qiu-hui GUO, Feng ZHAO, Xiao-jie XU, Yong-hong LIAO, Yun-fei LI. Advances of inhaled vaccine research[J]. Acta Pharmaceutica Sinica, 2025 , 60 (4) : 875 -883 . DOI: 10.16438/j.0513-4870.2024-0984
Year 2025 volume 60 Issue 4
PDF
200
86
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-0984
  • Receive Date:2024-09-10
  • Online Date:2025-10-29
  • Published:2025-04-12
Article Data
Affiliations
History
  • Received:2024-09-10
  • Revised:2024-12-25
Affiliations
    1Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
    2Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China
    3Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, Shandong University, Qingdao 266237, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-0984
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT